The Management of HIV Care Services in Central and Eastern Europe: Data from the Euroguidelines in Central and Eastern Europe Network Group
- PMID: 35805250
- PMCID: PMC9265352
- DOI: 10.3390/ijerph19137595
The Management of HIV Care Services in Central and Eastern Europe: Data from the Euroguidelines in Central and Eastern Europe Network Group
Abstract
Introduction: The COVID-19 pandemic has been challenging time for medical care, especially in the field of infectious diseases (ID), but it has also provided an opportunity to introduce new solutions in HIV management. Here, we investigated the changes in HIV service provision across Central and Eastern European (CEE) countries before and after the COVID-19 outbreak.
Methods: The Euroguidelines in Central and Eastern Europe Network Group consists of experts in the field of ID from 24 countries within the CEE region. Between 11 September and 29 September 2021, the group produced an on-line survey, consisting of 32 questions on models of care among HIV clinics before and after the SARS-CoV-2 outbreak.
Results: Twenty-three HIV centers from 19 countries (79.2% of all countries invited) participated in the survey. In 69.5% of the countries, there were more than four HIV centers, in three countries there were four centers (21%), and in four countries there was only one HIV center in each country. HIV care was based in ID hospitals plus out-patient clinics (52%), was centralized in big cities (52%), and was publicly financed (96%). Integrated services were available in 21 clinics (91%) with access to specialists other than ID, including psychologists in 71.5% of the centers, psychiatrists in 43%, gynecologists in 47.5%, dermatologists in 52.5%, and social workers in 62% of all clinics. Patient-centered care was provided in 17 centers (74%), allowing consultations and tests to be planned for the same day. Telehealth tools were used in 11 centers (47%) before the COVID-19 pandemic outbreak, and in 18 (78%) after (p = 0.36), but were represented mostly by consultations over the telephone or via e-mail. After the COVID-19 outbreak, telehealth was introduced as a new medical tool in nine centers (39%). In five centers (28%), no new services or tools were introduced.
Conclusions: As a consequence of the COVID-19 pandemic, tools such as telehealth have become popularized in CEE countries, challenging the traditional approach to HIV care. These implications need to be further evaluated in order to ascertain the best adaptations, especially for HIV medicine.
Keywords: COVID-19; Central and Eastern Europe; HIV; models of care; telehealth.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
HIV care in times of the COVID-19 crisis - Where are we now in Central and Eastern Europe?Int J Infect Dis. 2020 Jul;96:311-314. doi: 10.1016/j.ijid.2020.05.013. Epub 2020 May 11. Int J Infect Dis. 2020. PMID: 32413608 Free PMC article.
-
National strategies for vaccination against COVID-19 in people living with HIV in Central and Eastern European region.HIV Med. 2022 May;23(5):546-552. doi: 10.1111/hiv.13194. Epub 2021 Oct 26. HIV Med. 2022. PMID: 34704331 Free PMC article.
-
The Presence of Either Typical or Atypical Radiological Changes Predicts Poor COVID-19 Outcomes in HIV-Positive Patients from a Multinational Observational Study: Data from Euroguidelines in Central and Eastern Europe Network Group.Viruses. 2022 May 5;14(5):972. doi: 10.3390/v14050972. Viruses. 2022. PMID: 35632714 Free PMC article.
-
Implications of telehealth and digital care solutions during COVID-19 pandemic: a qualitative literature review.Inform Health Soc Care. 2021 Mar 2;46(1):68-83. doi: 10.1080/17538157.2020.1839467. Epub 2020 Nov 29. Inform Health Soc Care. 2021. PMID: 33251894
-
Radiation Oncology in the Developing Economies of Central and Eastern Europe.Semin Radiat Oncol. 2017 Apr;27(2):150-157. doi: 10.1016/j.semradonc.2017.01.001. Epub 2017 Jan 23. Semin Radiat Oncol. 2017. PMID: 28325241 Review.
Cited by
-
PrEP Scale-Up and PEP in Central and Eastern Europe: Changes in Time and the Challenges We Face with No Expected HIV Vaccine in the near Future.Vaccines (Basel). 2023 Jan 4;11(1):122. doi: 10.3390/vaccines11010122. Vaccines (Basel). 2023. PMID: 36679967 Free PMC article.
-
Integrated use of laboratory services for multiple infectious diseases in the WHO European Region during the COVID-19 pandemic and beyond.Euro Surveill. 2022 Jul;27(29):2100930. doi: 10.2807/1560-7917.ES.2022.27.29.2100930. Euro Surveill. 2022. PMID: 35866437 Free PMC article.
References
-
- Collins L.F., Colasanti J.A., Nguyen M.L., Moran C.A., Lahiri C.D., Marconi V.C., Armstrong W.S., Shah N.S. The COVID-19 pandemic as a catalyst for differentiated care models to end the HIV epidemic in the United States: Applying lessons from high-burden settings. AIDS. 2020;35:337–341. doi: 10.1097/QAD.0000000000002746. - DOI - PMC - PubMed
-
- Skrzat-Klapaczyńska A., Matłosz B., Otelea D., Harxhi A., Vassilenko A., Bolokadze N., Rüütel K., Papadopoulos A., Mardarescu M., Youle M., et al. Epidemiological characteristics and access to end-stage liver disease care for HIV-positive patients with HCV and/or HBV coinfections in Central/Eastern European and neighboring countries–data from the ECEE network. Prz. Epidemiol. 2019;73:61–68. doi: 10.32394/pe.73.07. - DOI - PubMed
-
- Balayan T., Oprea C., Yurin O., Jevtovic D., Begovac J., Lakatos B., Sedlacek D., Karpov I., Horban A., Kowalska J.D., et al. People who inject drugs remain hard-to-reach population across all HIV continuum stages in Central, Eastern and South Eastern Europe–data from Euro-guidelines in Central and Eastern Europe Network. Infect. Dis. 2019;51:277–286. doi: 10.1080/23744235.2019.1565415. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous